Register now
To access the site, please provide the required information to verify that you are a Canadian healthcare professional and create an account. Once validated, this account can be used to log in to all myAstraZeneca websites for Canadian healthcare professionals. Please use the first and last name registered with your professional college.
There are different dosing instructions according to indication and strength of inhaler. The SYMBICORT TURBUHALER dosage strengths in Canada include:
Please see the Product Monograph for complete dosing and administration instructions.
The appropriate SYMBICORT TURBUHALER dosage for adults and adolescents should be selected on an individualized basis according to disease severity.
Mild persistent asthma
Moderate or severe asthma
Moderate or severe asthma
SYMBICORT TURBUHALER is not currently recommended in children younger than 18 years of age for the treatment of COPD or younger than 12 years of age for the treatment of asthma.
There are no special dosage requirements for elderly patients.
There are no data available for the use of SYMBICORT TURBUHALER in patients with hepatic or renal impairment.
There are no data available from clinical trials on overdose with SYMBICORT TURBUHALER.
Access the following tools to help inform your patients about administering their SYMBICORT TURBUHALER, including how to prepare a new inhaler and how to take a dose.
How to use SYMBICORT TURBUHALER Guide
How to use SYMBICORT TURBUHALER Video
How to use SYMBICORT TURBUHALER Guide
How to use SYMBICORT TURBUHALER Video
BID: twice daily; COPD: chronic obstructive pulmonary disease; PRN: as needed.
* SYMBICORT 100 TURBUHALER and SYMBICORT FORTE TURBUHALER should not be used as SYMBICORT Anti-Inflammatory Reliever therapy.
Reference: